Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
ASH 
Ashland Global Holdings Inc (ASH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: ASH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
11 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $63.6
1 Year Target Price $63.6
| 6 | Strong Buy |
| 1 | Buy |
| 4 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -26.6% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.24B USD | Price to earnings Ratio - | 1Y Target Price 63.6 |
Price to earnings Ratio - | 1Y Target Price 63.6 | ||
Volume (30-day avg) 11 | Beta 0.48 | 52 Weeks Range 44.51 - 86.49 | Updated Date 10/16/2025 |
52 Weeks Range 44.51 - 86.49 | Updated Date 10/16/2025 | ||
Dividends yield (FY) 3.33% | Basic EPS (TTM) -17.97 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -46.07% | Operating Margin (TTM) 7.34% |
Management Effectiveness
Return on Assets (TTM) 1.78% | Return on Equity (TTM) -34.43% |
Valuation
Trailing PE - | Forward PE 10.79 | Enterprise Value 3496567201 | Price to Sales(TTM) 1.2 |
Enterprise Value 3496567201 | Price to Sales(TTM) 1.2 | ||
Enterprise Value to Revenue 1.87 | Enterprise Value to EBITDA 53.88 | Shares Outstanding 45705958 | Shares Floating 41789872 |
Shares Outstanding 45705958 | Shares Floating 41789872 | ||
Percent Insiders 1.08 | Percent Institutions 97.86 |
Upturn AI SWOT
Ashland Global Holdings Inc
Company Overview
History and Background
Ashland Global Holdings Inc. was founded in 1924 as Ashland Refining Company. Initially focused on oil refining and road construction, it has evolved into a global specialty chemicals company. Significant milestones include expansion into chemicals, strategic acquisitions, and divestitures to focus on its core specialty ingredients business.
Core Business Areas
- Specialty Additives: This segment develops and markets specialty additives and functional ingredients used in a variety of applications, including adhesives, architectural coatings, automotive, construction, energy, personal care, and pharmaceuticals.
- Intermediates and Solvents: This segment includes products such as 1,4 butanediol (BDO), tetrahydrofuran (THF), n-methylpyrrolidone (NMP), and maleic anhydride (MA).
Leadership and Structure
Ashland is led by Guillermo Novo (Chairman & CEO) and has a typical corporate structure with functional departments (Finance, Marketing, Operations, etc.) reporting to the CEO. The board of directors oversees the company's strategic direction.
Top Products and Market Share
Key Offerings
- Product Name 1: Adhesives: Ashland's adhesives are used in various industries, including packaging, construction, and automotive. Competitors include H.B. Fuller (FUL) and Henkel (HENKY).
- Product Name 2: Coatings: Ashland offers a range of coating additives that enhance the performance of architectural and industrial coatings. Competitors include Dow (DOW) and BASF (BASF).
- Product Name 3: Personal Care Ingredients: Ashland produces ingredients for personal care products, such as hair care, skin care, and cosmetics. Competitors include Evonik (EVKIF) and Croda (CRDA.L).
Market Dynamics
Industry Overview
The specialty chemicals industry is characterized by innovation, customization, and a focus on performance. Demand is driven by trends in end markets such as construction, automotive, personal care, and pharmaceuticals.
Positioning
Ashland is a leading provider of specialty additives and functional ingredients. Its competitive advantages include its deep technical expertise, strong customer relationships, and global manufacturing footprint.
Total Addressable Market (TAM)
The global specialty chemicals market is estimated to be worth hundreds of billions of dollars. Ashland is positioned to capture a significant portion of this market by focusing on high-growth segments and developing innovative solutions.
Upturn SWOT Analysis
Strengths
- Strong market position in specialty additives
- Global manufacturing and distribution network
- Deep technical expertise and innovation capabilities
- Strong customer relationships
- Diversified end markets
Weaknesses
- Exposure to raw material price volatility
- Cyclicality of some end markets
- Dependence on key suppliers
- High debt compared to competitors
Opportunities
- Growing demand for specialty chemicals in emerging markets
- Increasing adoption of sustainable and bio-based materials
- Expansion into new applications and end markets
- Strategic acquisitions and partnerships
- Digitalization and process optimization
Threats
- Economic downturns and recessions
- Intense competition from other specialty chemical companies
- Regulatory changes and environmental concerns
- Disruptive technologies and new entrants
- Fluctuations in currency exchange rates
Competitors and Market Share
Key Competitors
- DOW
- BASF
- ECL
Competitive Landscape
Ashland is positioned as a specialty chemicals provider, and competes against companies that have a broader portfolio, with some competitors having a competitive advantage in price due to economies of scale.
Major Acquisitions
Pharmachem
- Year: 2017
- Acquisition Price (USD millions): 660
- Strategic Rationale: Pharmachem acquisition was made to gain access to its nutritional ingredients technologies and expanded Ashlandu2019s presence in nutraceuticals.
Growth Trajectory and Initiatives
Historical Growth: Ashland's historical growth has been driven by acquisitions, new product development, and expansion into new markets. The growth rate has varied depending on economic conditions and strategic initiatives.
Future Projections: Future growth projections can be gathered from analyst estimates from financial news websites.
Recent Initiatives: Recent initiatives would include any new acquisitions, divestitures, product launches, or strategic partnerships. These need to be checked through press releases.
Summary
Ashland is a specialty chemical company with a strong position in additives and functional ingredients but faces cyclical end markets and exposure to raw material prices. Its technical expertise, and customer relationships are its strength. It will have to monitor the potential for economic downturns, competition, regulatory changes, and the effect of currency exchange rates. The recent acquisition of Pharmachem has helped it expand its nutraceuticals presence.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings, industry reports, press releases, financial news sources
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered investment advice. Market conditions and company performance can change rapidly, so it is essential to conduct thorough due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Ashland Global Holdings Inc
Exchange NYSE | Headquaters Wilmington, DE, United States | ||
IPO Launch date 1983-04-06 | Chairman & CEO Mr. Guillermo Novo | ||
Sector Basic Materials | Industry Specialty Chemicals | Full time employees 2960 | Website https://www.ashland.com |
Full time employees 2960 | Website https://www.ashland.com | ||
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.